Aquinox Pharmaceuticals stock skyrockets 450%
Shares of Canadian drug company Aquinox Pharmaceuticals Inc. skyrocketed more than 450% Friday after the company released positive mid-stage trial results for an inflammation therapy targeted toward patients with bladder pain syndrome, or interstitial cystitis. Its shares traded around $10.15 on Friday afternoon after closing at $1.79 on Thursday. Nearly 58 million shares shares have been traded, compared with the stock's 30-day average of 199,000. Small-cap biotech and drug companies tend to... Читать дальше...